PEPCAD III Substudy: Stem Cell Mobilization

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
The aim of the PEPCAD III substudy is to assess the efficacy of the Paclitaxel-eluting DEBlue stent system in the treatment of stenoses in native coronary arteries compared to the Sirolimus-eluting Cypher stent by intravascular ultrasound (IVUS) and to study the influence of both devices on endothelial function, coronary flow reserve, and stem cell mobilization.
Epistemonikos ID: 7e85a6fa42e80a38204fa510d189100e57695147
First added on: May 04, 2024